• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

8.041 -0.779 (-8.83%)
Streaming Delayed Price Updated: 11:22 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Vanda Pharmaceuticals Inc. - Common Stock

News headline image
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
February 03, 2025
From AnaptysBio, Inc.
Via GlobeNewswire
News headline image
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
December 16, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
August 06, 2024
New research suggests that powerful magnets could effectively treat bipolar disorder. This therapy, which is known as accelerated intermittent theta burst stimulation (iTBS), uses magnetic waves... 
Via PressReach
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Near the Top of Equities by Percentage Gain on 4/3
April 03, 2024
Via Investor Brand Network
News headline image
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
June 10, 2024
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
April 25, 2024
From Shareholder Capital LLC
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap